Alpha Teknova Inc. (TKNO)
7.91
-0.17 (-2.10%)
At close: Jan 14, 2025, 3:59 PM
7.91
0.00%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 7.66 |
| Market Cap | 421.66M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.72 |
| PE Ratio (ttm) | -10.99 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 12.65 |
| Volume | 216,089 |
| Avg. Volume (20D) | 283,498 |
| Open | 8.10 |
| Previous Close | 8.08 |
| Day's Range | 7.66 - 8.42 |
| 52-Week Range | 1.16 - 9.72 |
| Beta | undefined |
About TKNO
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sa...
Sector Healthcare
IPO Date Jun 25, 2021
Employees 210
Stock Exchange NASDAQ
Ticker Symbol TKNO
Website https://www.teknova.com
Analyst Forecast
According to 2 analyst ratings, the average rating for TKNO stock is "Buy." The 12-month stock price forecast is $5, which is a decrease of -36.79% from the latest price.
Buy 50.00%
Hold 50.00%
Sell 0.00%
Next Earnings Release
Alpha Teknova Inc. is scheduled to release its earnings on Mar 10, 2025,
during market hours.
Analysts project revenue of $8.78M, reflecting a 11.61% YoY growth and earnings per share of -0.12, making a -53.85% decrease YoY.
Analysts project revenue of $8.78M, reflecting a 11.61% YoY growth and earnings per share of -0.12, making a -53.85% decrease YoY.
2 months ago ·
Source
+3.92%
Alpha Teknova shares are trading higher after the ...
Unlock content with
Pro Subscription
